Quantitative data and new radiotracers developed for PET/CT boost detection of lung cancer while reducing false positives, according to research presented at the RSNA meeting.
Quantitative data and new radiotracers developed for PET/CT boost detection of lung cancer while reducing false positives, according to research presented at the RSNA meeting.
Some of the studies contradict long-held beliefs about how best to use PET/CT for this application. For example, while previous research has supported the view that CT's tissue density attenuation and FDG-PET's standardized uptake value (SUV) have no business together, researchers at the RSNA offered a radically different view.
Dr. Kiyoshi Nishikawa and colleagues from the Miyazaki and Tsukuba universities in Japan assessed 93 patients with PET/CT. The investigators measured average Hounsfield units (HU) and SUV in the region of interest around pulmonary abnormalities.
The team found the combined anatomic/functional quantitative assessments were clinically useful to detect malignancies, even if these lesions are missed or misinterpreted by the PET component.
In another study, Dr. Irfan Farukhi from the University of Texas Southwestern Medical Center in Dallas presented results of his research based on 53 randomized patients. The team had noted previously the difficulty in differentiating benign granulomatose disease from neoplasms using hybrid imaging. In the current study, Farukhi and colleagues combined HU density values from 3D volumetric CT with conventional SUV to improve characterization. They found the technique increased PET/CT sensitivity and specificity to differentiate benign from malignant pulmonary lesions.
Another research team, headed by Drs. Qiang Li and Yongkang Nie from the University of Chicago, developed a computer-aided diagnostic system to improve PET interpretation, based on a database of PET/CT images.
The CAD system uses a selective enhancement filter that boosts tumors while suppressing normal anatomic structures. The system then applies a discrimination algorithm to weed out false positives. Using this scheme, investigators achieved a high detection rate for true malignancies and lowered PET's false-positive rate.
A final study by Jamey Weichert, Ph.D., and colleagues from the University of Wisconsin-Madison unveiled preliminary results with the new SPECT ligand iodine131-
labeled NM404 on six patients with advanced non-small cell lung cancer. They found the patients tolerated the NM404 well. They also observed similar tumor uptake and retention properties in human NSCLC as previously observed in mice undergoing imaging with this agent. Studies are underway to extend the utility of NM404 to PET.
"While it is not logistically feasible to expect any one agent to trace every molecular process, knowing of one, such as NM404, that may have a broad applicability is certainly intriguing," said Dr. Richard L. Wahl, director of nuclear medicine at Johns Hopkins. "Although we have years of work left ahead, PET/CT seems to be working well for lung cancer imaging worldwide," he said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.